- TriHealth names chief people officer
- Why hospitals should step away from data as the deliverable, per 1 exec
- State orders NYU Langone to restore gender care for youth
- San Diego provider opens 32-bed residential mental health facility
- Google’s pay for 3 health tech jobs
- Nevada hospital to downsize, switch to rural emergency status
- Nevada hospital to downsize, switch to rural emergency status
- Missouri system taps chief medical officer
- Moody’s downgrades Arkansas system’s credit rating
- Moody’s downgrades Arkansas system’s credit rating
- Mental health providers subject to ban on youth ‘transition’ procedures: Texas attorney general
- Epic, Oracle submit AI policy recommendations to HHS
- 5 gastroenterologist moves in 1 month
- Cost Plus Drugs partners to give hospitals easier access
- What’s new with Kaiser Permanente?
- 4 hospital, health system layoffs in February
- U of Mississippi pharmacy program targets maternal health crisis
- Innovate 32 continues growth, adds 2 dental practices in Tennessee
- Indiana hospital transitions revenue cycle operations to Revology
- New York surgery center inks anesthesia deal
- Mayo Clinic posts 6.8% margin in 2025
- 5 anesthesiologists in the headlines
- Listen to the Latest ‘KFF Health News Minute’
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Woodside Health acquires Arizona facility
- New York physician sentenced to 7 years for unlawful drug distribution
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- How to Get Ready For Daylight Saving Time
- A-Fib Drug Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Effective Sunscreen Protection Can Cost $40 A Year
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- OhioHealth builds well-being programs to reshape caregiver culture
- UF Health taps new outpatient senior VP
- UAMS names new director of cardiovascular medicine division
- CMS’ add-on billing code boosts specialist pay: Study
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- New Jersey woman charged with practicing unlicensed dentistry
- 100+ organizations call on CMS to revise 2027 MA rates
- Oklahoma advances interstate compact bill
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- The Smilist expands into Virginia
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- In 1 state, large hospitals dominate 340B's net savings
- 15 dentists making headlines
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- PDS Health added de novos across 3 states in February
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- Iowa dentist surrenders license
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Partnering to Advance Drug Delivery Innovation
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
Michigan Economic Development Corporation (MEDC) is also known as the slush fund for the Governor's cronies. MEDC sends out regular emails listing its various spending projects featured in the media.
Under the Snyder administration, daily emails featured 2-3 articles impacting healthcare.
Under the Whitmer administration, I see fewer than 1 per month. (Not watching as closely, I may miss a few.)
Yes, elections do make a difference.
Alerje in Detroit Partners with Mitsubishi to Revolutionize Allergy Care
Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.
The synergy is expected to create a comprehensive, personalized allergy care solution that could significantly improve patient outcomes and quality of life. Food allergies affect 220 million people globally.
Key aspects of the partnership include:
- Joint efforts to bring advanced allergy diagnostic platforms to the United States market.
- Integration of food allergy technologies, aiming to create a holistic approach to personalized allergy care.
- This collaboration aligns with MGC’s strategic long-term plan, focusing on medical and food sectors.
“This partnership with MGC represents a significant milestone in our mission to improve the lives of millions affected by allergies,” says Javier Evelyn, founder and CEO of Alerje. “With our powers combined, we’re poised to deliver unprecedented advancements in allergy diagnosis and management.”
The partnership focuses on rethinking food allergy care. The work combines better testing with innovative therapies, aiming to change how people live with food allergies. The goal is to help people with food allergies live freely, not just cope with symptoms.
“We are excited about the potential of this collaboration with Alerje,” says Yoshinori Isahaya, director, managing executive officer at MGC. “Together, we aim to set new standards in allergy care, leveraging our combined technologies and expertise to address unmet needs in both the U.S. and Japanese markets.”
Alerje integrates emergency medicine with AI enabled digital health tools, and offers a remote patient monitoring platform backed by the National Science Foundation.
The platform gathers and processes vital information as well as predicts treatment outcomes, which enhances care strategies for allergists. Alerje’s internationally patented technology combines a low-cost life-saving epinephrine auto-injector with a smartphone case, ensuring patients have immediate access to medication, thus redefining adherence and emergency response.
Mitsubishi Gas Chemical is a leading global chemical company that develops and manufactures a wide range of products in the fields of basic chemicals, fine chemicals, and functional materials. With a strong focus on innovation and sustainability, MGC contributes to society through chemistry-based solutions.
For more information, visit alerje.com/.
Alerje has two primary products which can help patients with managing food allergies: the first being an epinephrine autoinjector that is attached to the patient's phone, the second being phone application to help track immunotherapy treatments.
In my experience as an EMT, patient outcomes for anaphylaxis have been better for those who received epinephrine earlier. If a patient is suffering from a highly severe allergy, having an autoinjector attached to their phone may be a good idea.
https://www.alerje.com/take-control
Introducing The Omniject™
Studies have shown* that when it comes to anaphylactic reactions, even minutes count. Get back to your life with less worry.
The patented smartphone-attached Omniject™ epinephrine auto-injector prioritizes storage, convenience, and safety.
Adhered to your phone case, Alerje's Ominiject™ will always be with you in case of emergency and will stay at the appropriate temperature for maximum epinephrine effectiveness.
Automatic alerts to the patient’s allergist, first responders, and support circle if a dose from the case is activated.
AIT by Alerje
Achieve life's goals beyond food allergies: Oral Immunotherapy (OIT) management to get you to the maintenance finish line.
Keeps you and your allergist connected, simplifying the Oral Immunotherapy process, plus treatment-specific resources.
Rewards and celebrates you for achieving OIT milestones and collects mental health data to share with your allergist, helping you work together to win OIT and achieve treatment goals.
Reminders to take your dose, alerting you and your allergist in case of missed doses through daily tracking.
There's no doubt the idea has merit.
The essential forgotten question in health policy today is whether government should do, or fund, or mandate A, B, or C. Remember limited government?
Law is force. Government acts only by taking our taxes. Too often, it uses them not to serve the general welfare, but according to its own priorities. (Politics, for example.)
The only way to avoid the special interest quagmire is to say No to such "public investing."
Legislators should shut down the governor's slush fund. The governor should send corporate beggars in a quick about-face to banks, friends, and other private lenders.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
